MIRAGEN THERAPEUTICS INC - COM (MGEN)

CUSIP: 60463E103

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
4,437,126
Share change
+426,756
Total reported value
$57,371,106
Price per share
$12.93
Number of holders
30
Value change
+$5,577,160
Number of buys
26
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q2 2017

As of 30 Jun 2017, MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,437,126 shares. The largest 10 holders included FMR LLC, BlackRock Inc., GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, STATE STREET CORP, UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO, VANGUARD GROUP INC, TIAA CREF INVESTMENT MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.